IDEXX Laboratories, Inc. (IDXX)
NASDAQ · Healthcare
IDEXX Laboratories, Inc. Total Liabilities 2008–2025
IDEXX Laboratories, Inc. annual total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- IDEXX Laboratories, Inc. total liabilities as of December 31, 2025: 1.75B, a 2.78% increase year-over-year.
- IDEXX Laboratories, Inc. total liabilities for 2025 were 1.75B, a 2.78% increase from 2024.
- IDEXX Laboratories, Inc. total liabilities for 2024 were 1.70B, a 4.35% decrease from 2023.
- IDEXX Laboratories, Inc. total liabilities for 2023 were 1.78B, a 16.96% decrease from 2022.
- IDEXX Laboratories, Inc. total liabilities for 2022 were 2.14B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| IDEXX Laboratories, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,745 |
| 2024 | $1,698 |
| 2023 | $1,775 |
| 2022 | $2,138 |
| 2021 | $1,747 |
| 2020 | $1,662 |
| 2019 | $1,655 |
| 2018 | $1,547 |
| 2017 | $1,767 |
| 2016 | $1,639 |
| 2015 | $1,559 |
| 2014 | $1,267 |
| 2013 | $712 |
| 2012 | $467 |
| 2011 | $491 |
IDEXX Laboratories, Inc. Total Liabilities — FAQ
IDEXX Laboratories, Inc. (IDXX) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IDXX's total liabilities history?
The chart and table above show IDEXX Laboratories, Inc.'s total liabilities by year and by quarter, including the growth rate.